Search
Now showing items 1-10 of 14
-
The stem cell-associated gene expression signature allows risk stratification in pediatric acute myeloid leukemia
Leukemia, Springer Nature, 08-08-2018, 33; 2, 348-357Compte-rendu et recension critique d'ouvrage -
Biomarkers of Gemtuzumab Ozogamicin Response for Acute Myeloid Leukemia Treatment
International Journal of Molecular Sciences, MDPI, 06-08-2020, 21; 16, 5626Compte-rendu et recension critique d'ouvrage -
Comprehensive molecular landscape in patients older than 80 years old diagnosed with acute myeloid leukemia: A study of the French Hauts-de-France AML observatory
American Journal of Hematology, 2019, 94; 1, E24-E27Article dans une revue scientifique -
The stem cell-associated gene expression signature allows risk stratification in pediatric acute myeloid leukemia
Leukemia, Springer Nature, 08-08-2018, 33; 2, 348-357Compte-rendu et recension critique d'ouvrage -
Germline PAX5 mutation predisposes to familial B-cell precursor acute lymphoblastic leukemia
Blood, American Society of Hematology, 11-03-2021, 137; 10, 1424-1428Compte-rendu et recension critique d'ouvragefulltext -
Early detection of WT1 measurable residual disease identifies high-risk patients, independent of transplantation in AML
Blood advances, The American Society of Hematology, 14-12-2021, 5; 23, 5258-5268Compte-rendu et recension critique d'ouvragefulltext -
Prognostic significance of concurrent gene mutations i n intensively treated patients with IDH-mutated AML: an ALFA study
Blood, American Society of Hematology, 2021, 137; 20, 2827-2837Compte-rendu et recension critique d'ouvragefulltext -
A personalized approach to guide allogeneic stem cell transplantation in younger adults with acute myeloid leukemia
Blood, American Society of Hematology, 2021, 137; 4, 524-532Compte-rendu et recension critique d'ouvragefulltext -
Clonal Dynamics of FLT3 -ITD Positive Acute Myeloid Leukemia Patients with Relapsed/Refractory Disease Following Intensive Chemotherapy +/- Midostaurin
Blood, American Society of Hematology, 28-11-2023, 142; Supplement 1, 976-976Compte-rendu et recension critique d'ouvragefulltext -
Mutational profile and benefit of gemtuzumab ozogamicin in acute myeloid leukemia
Blood, American Society of Hematology, 20-02-2020, 135; 8, 542-546Compte-rendu et recension critique d'ouvrage